The effect of low doses of naloxone on the preovulatory surge of LH and on the onset and duration of oestrus in the ewe with induced oestrus during the non-breeding season

Effect of small doses of naloxone on sexual exhaustion in White New Zealand male rabbits

The objective of the present study was to determine the effect of small doses of naloxone on sexual exhaustion in White New Zealand male rabbits. Twelve young and 12 adult male rabbits 6-12 months old and 14-20 months of age, respectively, were selected from a commercial farm. Each male rabbit was housed individually in galvanized cages (90 cm x 60 cm x 40 cm). The rabbits were housed in an open shed exposed to natural photoperiod (12 L 12 D, 19 degrees N). Daily temperature fluctuated through the year from 28 to 16 degrees C. Humidity was 45+/-5%. Water and food (rabbit chow PMI) was supplied ad libitum. After sexual behaviour for each studied group was established, the males were given a 6-day rest, and 3 days before next trial, six males of each group (treated) received a subcutaneous implant of 8 mg of naloxone in a crystalline nitrocellulose pellet formulated to be completely absorbed in 15 days. The remaining six males were sham-treated (control). At the end of the resting period as previously described, the sexual behavior of each group was studied and compared using a Mann-Whitney statistical U-test. The effect of naloxone on sexual behavior was analyzed with a Wilcoxon test for correlated samples. With regard to sexual activity between young and adult rabbits, it was observed that there was a significant difference between groups (P=0.00275, Z=2.8823, adjusted Z=2.99.43) showing that younger rabbits mounted/ejaculated from 9 to 10 females compared with 6 to 8 mounted/ejaculated by older rabbits. When naloxone was administered to both groups, there was a significant difference when comparing sexual behavior before and after administration of naloxone (table first and second trial). Young rabbits treated with naloxone mounted/ejaculated 11-12 females while older rabbits mounted nine females before reaching sexual exhaustion. A significant difference was observed when comparing the number of estrous females that were mounted/ejaculated between groups. Environmental photoperiod and temperature changes were not considered. It was concluded that endogenous opioids are important modulators of behavioral and hormonal interactions related to sexual behavior.

The effect of small doses of naloxone on the initiation and duration of the first estrus after weaning in sows

The present research was conducted with the objective of studying the pharmacological effect of small doses of naloxone on the initiation and duration of the first estrus after weaning in the sow. For this purpose, 32 multiparous sows were used. Sows were divided at random into two groups. Group 1 (n=16) was treated by i.m. injection with 2mg naloxone at 12h intervals from 3 days before until 3 days after weaning. Group 2 (n=16) served as the control group and received saline solution at the same times as treatments for group 1. First estrus after weaning occurred at 85+/-5.2 and 108.3+/-5h (P<0.05) in naloxone- and saline-treated sows. Duration of estrus was 89.6+/-3.9 and 49.6+/-3.9h (P<0.05) in naloxone-treated and control animals, respectively. It was concluded that naloxone treatment advanced the time of appearance and duration of the first estrus after weaning in sows giving further support that endogenous opioids (EOP) are modulators of sexual behavior in female pigs.

Endogenous opiates and behavior: 2001

This paper is the twenty-fourth installment of the annual review of research concerning the opiate system. It summarizes papers published during 2001 that studied the behavioral effects of the opiate peptides and antagonists. The particular topics covered this year include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology(Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17).